Health
SK Bioscience starts developing vaccine against Covid-19 variants – Korea Biomedical Review
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness…
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness Innovations (CEPI), an international private organization.
The Korean company will receive up to $14.2 million (about 16 billion won) in research and development funds from CEPI to develop Covid-19 mutants using the development platform of GBP510, for which clinical trials are now underway.
SK Bioscience said it had also received additional…
-
Noosa News18 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
General22 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News14 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense
-
Business18 hours agoHow did the market react to this dividend stock’s earnings results?